Fatty-acid amide hydrolase (FAAH) is a membranebound enzyme that degrades neuromodulatory fatty acid amides, such as oleamide and anandamide, and is expressed in the mammalian central nervous system. To evaluate FAAH genes as candidates for neurogenetic diseases in humans and mice, we have mapped the loci in both species and have determined their intron-exon structures. The human FAAH gene was mapped to region 1p34 -p35, closely linked to D1S197 and D1S443, by using PCR analysis of somatic cell hybrid (SCH) and radiation hybrid mapping panels. Analysis of an SCH mapping panel and a mouse interspecific backcross panel has localized the Faah gene to the conserved syntenic region on mouse chromosome 4, close to the neurological mutation clasper. Faah gene rearrangements were excluded by Southern blot analysis of clasper DNA. No sequence abnormality was detected in PCR products containing the 15 exons and splice junctions of the mouse Faah gene. FAAH protein levels were normal in clasper mouse tissues as determined by enzyme activity assays and Western blotting.
INTRODUCTION
Fatty-acid-amide hydrolase (FAAH) is a membranebound enzyme involved in the degradation of bioactive fatty acid amides. FAAH's substrates include the neuromodulatory signaling molecules oleamide and anandamide. Oleamide (cis-9-octadecenamide) is an endogenous sleep-inducing lipid originally isolated from the cerebrospinal fluid of sleep-deprived cats (Lerner et al., 1994; Cravatt et al., 1995) . In addition, oleamide can affect serotonergic systems by potentiating the response of 5-HT receptors to serotonin (Boger et al., 1998; Huidobro-Toro and Harris, 1996; Thomas et al., 1997a) . Anandamide was originally isolated from brain tissue as an endogenous ligand for the CB1 cannabinoid receptor (Devane et al., 1992) and has been shown to induce cannabinoid-like effects in mice (Smith et al., 1994) . Furthermore, both oleamide and anandamide have been found to block gap junction communication in glial cells (Guan et al., 1997) .
FAAH cDNAs have recently been cloned and characterized from rat, mouse, and human liver cDNA libraries (Cravatt et al., 1996; Giang and Cravatt, 1997) . Transient expression of the FAAH enzyme in COS-7 cells demonstrated that the enzyme was able to hydrolyze both oleamide and anandamide, as well as several other fatty acid amides (Cravatt et al., 1996) . In addition, in situ hybridization has revealed widespread distribution of rat FAAH mRNA in neuronal cells in the central nervous system (CNS) (Thomas et al., 1997b) . The primary structure of the enzyme is well conserved in mammals, with mouse and rat FAAHs sharing 91% of their amino acids and human FAAH being 82 and 84% identical to rat and mouse FAAH, respectively. As a metabolic enzyme coupled with endogenous neuromodulatory molecules, FAAH may play important roles in the CNS by ensuring rapid termination of signaling. To evaluate FAAH genes as candidates for neurogenetic diseases in humans and mice, we mapped the chromosomal locations of the human and mouse FAAH genes by using PCR analysis of two panels of somatic cell hybrid (SCH) lines and one radiation hybrid (RH) panel as well as by linkage analysis of a mouse interspecific backcross panel. We also determined the genomic structures of both human and mouse FAAH genes and evaluated the mouse FAAH gene as a candidate gene for the clasper mouse mutant.
MATERIALS AND METHODS
Somatic cell hybrids and PCR amplifications. The human FAAH gene was localized to a human chromosome by using a panel of 17 human ϫ Chinese hamster hybrid cell lines derived from several independent fusion experiments (Francke et al., 1986) . PCR primers (hFAAH-F 5Ј-GAGGCTTCCGTGTCCTCTC-3Ј and hFAAH-R 5Ј-CCTATGTCATACCCATGGGC-3Ј) were designed to specifically amplify a sequence of 138 bp from the 3Ј untranslated region (UTR) of the human FAAH gene. Genomic DNAs from the mapping panel were analyzed by PCR. Similarly, the mouse Faah gene was assigned to a mouse chromosome by PCR analysis of DNA from a mapping panel consisting of 19 mouse ϫ Chinese hamster somatic cell hybrid lines as described previously (Li et al., 1993) . Primers (sense, mFaah-2F, 5Ј-GGCCATCTTGAGGGTCATTC-3Ј; antisense, mFaah-1R, 5Ј-GGGAGCTGGTCCAGACTTG-3Ј) were designed to amplify a 197-bp fragment from the 3Ј UTR of the mouse Faah gene. PCR amplifications were carried out using 50 ng genomic DNA in 50-l final volume of 10 mM Tris-HCl (pH 8.3), 50 mM KCI, 1.25 mM MgCI 2 , 250 M each dNTP, and 2.5 U Taq DNA polymerase (Perkin-Elmer ABI, Foster City, CA). The PCR cycle conditions for both human and mouse FAAH gene amplifications were 94°C for 3 min and then 35 cycles of 94°C for 30 s, 55°C for 45 s, and 72°C for 1 min followed by 72°C for 5 min. The PCR products were sequenced to confirm their identities.
Human radiation hybrid mapping. A human RH mapping panel, GeneBridge 4, was used to confirm and define further the localization of the human FAAH gene (Walter et al., 1994) . Typing of the mapping panel was carried out by using the same 3Ј UTR human FAAH primers and PCR conditions described above. The maximum likelihood analysis (Boehnke et al., 1991) results were obtained by submitting the raw scores to http://www-genome.wi.mit.edu/cgi-bin/ contig/rhmapper.pl.
Linkage mapping with interspecific backcross mice and singlestrand conformation analysis (SSCA) . Fine localization of the mouse Faah gene was done by genotyping the interspecific backcross (C57BL/6JEi ϫ SPRET/Ei)F 1 ϫ SPRET/Ei (BSS) panel (The Jackson Laboratory DNA Mapping Resource, Bar Harbor, ME). To find a polymorphism, a 94-bp fragment was PCR amplified from DNA samples of the parental strains by using primer pair mFaah-1F (5Ј-CATGAGGAGATGCCCAGC-3Ј) and mFaah-1R (described above). Five microliters of PCR products were denatured and loaded onto a 12% nondenaturing polyacrylamide minigel for SSCA as described previously (Sugano et al., 1993) . All 94 DNA samples from the BSS panel were typed by PCR-SSCA and scored. The typing results were sent to The Jackson Laboratory backcross service for comparison with previous typing data of markers on mouse chromosome 4. The mouse Faah gene mapping figures were prepared by Lucy Rowe (The Jackson Laboratory).
Characterization of exon-intron boundaries of human and mouse FAAH genes. The genomic structures of the FAAH genes were determined by direct sequencing of bacterial artificial chromosome (BAC) genomic clones and comparing the sequence with the cDNA sequence. The human FAAH genomic BAC clone was isolated by PCR screening of human BAC DNA pools release III (Research Genetics, Inc., Huntsville, AL), with the same 3Ј UTR primers designed for mapping. The mouse FAAH genomic BAC clone was isolated by Genome Systems by hybridization with a 400-bp cDNA fragment from the 5Ј region as a probe. Both human and mouse FAAH BAC clones were grown in LB media containing 12.5 g/ml chloramphenicol. The BAC DNA was purified using the QIAGEN plasmid kit/QIAGEN-Tip 500 (Qiagen, Inc., Valencia, CA), following the manufacturer's protocol for purification of low-copy-number plasmids.
The putative splice sites in the human and mouse FAAH cDNA sequences (GenBank Accession Nos: U82535 for human and U82536 for mouse) were predicted using the Baylor College of Medicine Gene Finder Program at http://dot.imgen.bcm.tmc.edu:9331/gene-finder/ gf.html by choosing "HSPL/Search For Potential Splice Sites." Then forward and reverse primers were designed about 20 bp away from putative splice sites and used for sequencing the BAC inserts into the putative introns. Direct sequencing of BAC DNA was performed on an ABI Prism 377 DNA sequencer using the Big Dye Terminator Cycle Sequencing Kit (Perkin-Elmer ABI), following the protocol recommended by the manufacturer. Briefly, 5 g of BAC genomic DNA was used for each 20-l reaction containing 8 l Big Dye Terminator Mix and 15 pmol primers. The cycle conditions were 95°C for 5 min and then 35 cycles of 95°C for 30 s, 55°C for 20 s, and 60°C for 4 min. The intron-exon boundaries were determined by comparing the cDNA sequence and the corresponding genomic sequences using Sequencher 3.0 (GeneCodes Corporation, Ann Arbor, MI). The introns were PCR amplified using exonic primers, and the intron sizes were estimated by comparing the PCR products with 1-kb and 100-bp DNA size markers (GIBCO BRL, Gaithersburg, MD) as well as a 20-bp DNA ladder (McFrugal's Lab Depot) running on 3% agarose gels or by sequencing the PCR products directly using the same exonic PCR primers.
Mutation analysis of the mouse Faah gene. Genomic DNAs from a homozygous mutant mouse B6 ϫ BALB/cBy-cla/cla and a possibly heterozygous BALB/cBy-cla/ϩ mouse were purchased from The Jackson Laboratory. Southern blot analysis was carried out following a standard protocol (Sambrook et al., 1989) . All 15 exons of the mouse Faah gene were PCR amplified by using the intronic primers listed in Table 3 using 50 ng of genomic DNA in 50 l final volume of 10 mM Tris-HCl (pH 8.3), 50 mM KCI, 1.25 mM MgCI 2 , 250 M each dNTP, and 2.5 U Taq DNA polymerase. The PCR products were sequenced on the ABI Prism 377 DNA sequencer. The sequences were compared with published sequences (Giang and Cravatt, 1997) using Sequencher 3.0 to search for potential mutations.
FAAH enzyme assay and Western blot analysis. BALB/c, Black
Swiss, and B6 ϫ BALB/cBy-cla/ϩ mice were obtained from The Jackson Laboratory. Adult mice were sacrificed by cervical dislocation, and heart, liver, and brain tissues were isolated and Douncehomogenized in phosphate-buffered saline, and the protein was concentrated (D c Protein Assay kit; Bio-Rad). Protein from each tissue was analyzed by Western blotting (50 g protein) and by FAAH enzymatic assays (100 g protein) as described previously (Cravatt et al., 1995 (Cravatt et al., , 1996 , with the following exceptions: (1) affinity-purified anti-FAAH polyclonal antibodies raised against a FAAH-GST fusion protein (containing amino acids 30 -579 of FAAH; Patricelli et al., 1998) were used for Western blotting and (2) in the FAAH enzymatic assay, the conversion of [ 14 C]oleamide to oleic acid was quantified by phosphorimager analysis of thin-layer chromatography plates (Packard Phosphorimager).
RESULTS

Chromosomal Localization of the Human FAAH Gene
The human FAAH gene was first mapped to a human chromosome by PCR typing of an SCH mapping panel. A 138-bp PCR product was generated from DNA extracted from human cells and from five hybrid cell lines that contained human chromosome 1, but not from hamster DNA. The human-specific PCR product was not obtained from a hybrid cell line (XV-18A-10b) that contained only chromosome region 1p32-qter (data not shown). By concordant segregation and by exclusion of all other chromosomes, the human FAAH gene was assigned to chromosome region 1pter-p3200 (Fig. 1A) .
RH mapping confirmed the chromosomal location of the human FAAH gene and also identified the position of this gene relative to polymorphic markers on the linkage map. Seventeen of the 93 RH cell lines were positive for the human-specific FAAH gene signal (re-tention frequency 18.3%). By maximum likelihood analysis, the human FAAH gene was placed 3.36 cR from chromosome 1 marker CHLC.GATA72H07 (lod Ͼ 3.0) proximal to D1S443 and distal to D1S197 (Fig.  1B) . To get cytogenetic information about these two STS markers and the human FAAH gene, we looked for two more distantly located flanking markers and examined their chromosomal locations by searching available integrated mapping information in the literature and in the on-line genome center databases. The more distal marker D1S441 and the more proximal marker D1S200 were found on the Whitehead Institute integrated map, and their physical map positions corresponded to 1p34 -p35 (Bray-Ward et al., 1996) . Therefore, the FAAH gene is most likely located at 1p34 -p35 in a region that also contains the MPL gene, the human homolog of the mouse myeloproliferative leukemia virus gene v-mpl, a member of the cytokine receptor superfamily (Skoda et al., 1993) (Fig. 1) .
Chromosomal Mapping of the Mouse Faah Gene
The mouse Faah gene was first mapped to a mouse chromosome by PCR analysis of an SCH mapping panel as described under Materials and Methods. A 197-bp PCR product was amplified from genomic DNA extracted from mouse cells and from mouse ϫ Chinese hamster hybrid lines containing mouse chromosome 4 when primers mFaah-2F and mFaah-1R were used. The mouse Faah gene was assigned to chromosome 4 by complete concordance of the 197 bp PCR product with mouse chromosome 4 in these hybrid lines. All other mouse chromosomes were excluded by at least three discordant hybrids.
We also performed linkage mapping of the mouse Faah gene by PCR-SSCA genotyping of The Jackson Laboratory backcross BSS panel. A polymorphism was identified when primer pair mFaah-1F/mFaah-1R was used for PCR-SSCA. As shown in Fig. 2A , several bands were detected by SSCA; conformer a was present only in C57BL/6J and not in SPRET/Ei, while conformer b was specific for SPRET/Ei. The mouse Faah gene was mapped to a distal region of mouse chromosome 4, cosegregating with several other loci, including Mpl (Skoda et al., 1993) (Fig. 2B ). Since this part of mouse chromosome 4 contains a large conserved syntenic region with human chromosome 1p, the map location of the mouse Faah gene is consistent with assignment of the human FAAH gene to 1p34 -p35.
Characterization of Exon-Intron Boundaries of the Human and Mouse FAAH Genes
To facilitate screening for mutations in human genetic disorders or mouse mutants mapped close to the FAAH locus, we determined the genomic structure of the human and mouse FAAH genes. Two BAC genomic clones, each containing either the human or the mouse gene, were isolated by screening human and mouse BAC libraries, respectively. The intron-exon boundaries and flanking intron sequences were determined by using primers in the FAAH coding sequence for direct sequencing of BAC genomic DNA as templates. We found that both human and mouse FAAH genes contain 15 exons. The positions of all exon-intron boundaries are conserved. Exon 1 contains the consensus ATG translation initiation codon, and exon 15 contains the TGA translation stop codon and the polyadenylation consensus sequence for both human and mouse FAAH genes. The intron-exon boundaries are summarized in Table 1 and Table 2 . As shown in the tables, most splice sites match the AG/GT rule. Even the sizes of introns were strikingly similar (Fig. 3) , with the exceptions of intron 2, which spans ϳ5 kb in the human gene compared to ϳ0.2 kb in the mouse gene, and intron 7, which is ϳ2 kb in human and ϳ1 kb in mouse. The genomic structures of the human and mouse FAAH genes are compared in Fig. 3 .
Evaluation of the Mouse Faah Gene as a Candidate Gene for the clasper Mutation
Potential mutations in the mouse Faah gene in DNA samples from one homozygous and one possibly heterozygous clasper mouse were searched for by Southern blot analysis and by direct sequencing of PCR amplimers. Ten micrograms of DNA samples from both clasper mutant mice and from a normal C57BL/6J control mouse were digested with EcoRI and probed with a PCR-amplified mouse 1.9-kb cDNA probe. Two distinct bands, between 11 and 13 kb, were detected in both clasper and normal control DNA samples on Southern blots (data not shown). These results exclude any large-scale deletions, duplications, or rearrangements of the Faah gene in clasper mice. The intronbased primers listed in Table 3 were used to amplify and to sequence directly the PCR products. No mutation was found in the coding regions and splice junctions. Since mutations in promoter or regulatory elements located outside of the amplified regions would not have been detected, we compared the FAAH enzyme activities in tissues from normal and clasper mice.
Comparisons of FAAH enzyme activity in liver and brain tissues from adult normal (BALB/c and Black Swiss) and clasper mice revealed no significant differences in relative FAAH activities (Table 4) . Additionally, Western blotting showed equivalent FAAH protein levels in normal and clasper mice (Fig. 4) . Finally, no FAAH enzyme activity or protein was observed in heart tissue isolated from clasper mice, indicating that an upregulation of FAAH levels did not occur in these   FIG. 3 . Comparison of the genomic organization of the human and mouse FAAH genes. The coding regions are represented by filled boxes and untranslated regions by open boxes. The exon and intron sizes are drawn to scale. The intron sizes of the human gene are 1, ϳ330 bp; 2, ϳ5 kb; 3, 222 bp; 4, 81 bp; 5, 239 bp; 6, 160 bp; 7, ϳ2 kb; 8, ϳ550 bp; 9, ϳ1 kb; 10, 312 bp; 11, ϳ780 bp; 12, ϳ0.5 kb; 13, ϳ0.8 kb; 14, 235 bp. The intron sizes of the mouse gene are 1, ϳ450; 2, ϳ200 bp; 3, 158; 4, 93 bp; 5, ϳ270; 6, ϳ230 bp; 7, ϳ1 kb; 8, ϳ450 bp; 9, ϳ1 kb; 10, ϳ320 bp; 11, ϳ780 bp; 12, ϳ0.5 kb; 13, ϳ0.8 kb; 14, 224 bp. 
DISCUSSION
Comparative mapping of homologous genes on human and mouse chromosomes is a powerful means to study the evolution of genome organization and to identify candidate genes for genetic disorders. In this study, we mapped the human FAAH gene to chromosome region 1p34 -p35 and the mouse Faah gene to the distal portion of mouse chromosome 4, which contains a large region of conserved synteny with human chromosome 1p. The genomic structures of the human and mouse FAAH genes are highly conserved, with the same splice sites and similar sizes for both introns and exons. The conserved chromosomal locations and genomic structures strongly suggest that the FAAH enzyme plays a similar role in different mammals. Indeed, the FAAH enzymes are well conserved in primary structure from rat and mouse to human (Giang and Cravatt, 1997) . Transiently expressed rat and human FAAHs were found to share many biochemical and enzymological features (Giang and Cravatt, 1997) . In addition, in situ hybridization demonstrated widespread distribution of FAAH mRNA in neuronal cells in the rat CNS (Thomas et al., 1997b) . Interestingly, the present study revealed that the FAAH genes show an exon-intron structure compatible with certain functional protein domains being encoded by individual exon units. For example, FAAH's amidase signature sequence, which defines this family of enzymes, was found entirely within exon 5, the SH3-binding domain within exon 7, and the N-terminal transmembrane domain within exon 1. In this regard, recent studies have identified this transmembrane region of FAAH as an autonomously functioning homo-oligomerization domain (Patricelli et al., 1998) .
Degradation of neuromodulatory fatty acid amides by FAAH may have distinct physiological effects in the CNS, and mutations in the FAAH gene could potentially cause inheritable neurological disorders in mammals. The 1p36 -p34 region of human chromosome 1p, where the FAAH gene was mapped, carries genes for human neurogenetic diseases, such as SchwartzJampel syndrome (Fontaine et al., 1996; Singh et al., 1997; Timmerman et al., 1996) , hereditary congenital ptosis 1 (Engle et al., 1997) , and Charcot-Marie-Tooth neuropathy type 2A (Saito et al., 1997) . Several neurological mouse mutants, audiogenic seizure prone-2 (asp2), cerebellar folial pattern (Cfp1), cribriform degeneration (cri), meander tail (mea), and clasper (cla), have been mapped to chromosome 4 (Mouse Genome Database, Mouse Genome Informatics Project, The Jackson Laboratory: http://www.informatics.jax.org). Among the mouse mutants, cla is located most closely to the Faah gene (Mock et al., 1996) . Cla is a recessive neurological mutation that arose in BALB/cByJ mice. The clasper mice exhibit a whole-body tremor and hobbling gait with clasping of both fore-and hindfeet when picked up by the tail (Sweet, 1985) . Given that fatty acid amides have been shown to induce hypothermia and motor defects in mice (Mechoulam et al., 1997) , it was tempting to speculate that the clasper phenotype might represent an exaggerated reflex caused by failure of FAAH to downregulate certain fatty acid amide-mediated activities in the CNS. However, our thorough mutation analysis and enzymatic assays strongly suggest that the Faah gene is an unlikely candidate gene for the clasper mutation. Still, we cannot at this time exclude the possibility that transient changes in the developmental expression of FAAH could account for the clasper phenotype.
It is possible that mutations in the FAAH gene are involved in the development of other neurological disorders the genes for which will be mapped to mouse chromosome 4 or human chromosome 1p in the future. The best approach may be to create Faah mutant mice by gene targeting. The phenotypes of such FAAH-deficient mice may help to identify any existing neurological disorders as candidates for spontaneous FAAH mutations that can be tested directly for allelism with Faah Ϫ/Ϫ mice. The complete genomic characterization of the human and mouse FAAH genes reported here will facilitate the screening for mutations in these and other genetic disorders that become linked to this region in the future.
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